Thus, we may have missed somatic events on other genes described in CD such as USP48, TP53, BRAF etc. These variants may be detected through whole genome sequencing, which was performed for most tumor samples and yielded no hotspot variants in those genes. This evidence concerns the gene TP53 and neoplasm.